Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Giora Weisz MD
483
•Giora Weisz MD•October 24, 2019

Giora Weisz MD – FDA 483, Oct 24, 2019

Record Details

An FDA inspection of Giora Weisz MD in Bronx, NY, identified a significant deviation from the investigational plan. The firm failed to adhere to protocol for scheduled laboratory assessments and did not properly follow exclusion criteria for study subjects. This indicates a lack of compliance with established clinical trial procedures.

Company
Giora Weisz MD
Inspection date
October 24, 2019
Product type
drugs
Office
New York District Office
Person
  • Iram R. Hassan (investigator)
View Company Profile

ID · 20c8a88f-acb4-413a-a13f-98d6f7fd4a91

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Giora Weisz MD
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.